Nanobiotix

Nanobiotix is a nanomedicine company dedicated for the development of novel treatments and new therapeutics evolving based on the combined applications of nanotechnology and biotechnology for the local treatment of cancer. Nanobiotix researches and progresses biopharmaceutical medicine. Nanobiotix offers oncology nanomedicine treatments to control and treat cancer tumors. Bionanotechnology plays a critical role in both tissue engineering and drug delivery. Nanobiotix has improved a fresh class of therapeutics basing on nanoparticles and nanoxray therapeutics. They comprise of inert nanoparticles designed to enter in the tumor cells. They are injected straight through syringe into tumors, after stimulation by the standard dose of radiation, they relieve free radicals which destroys cancer cells. The lead product of the nanobiotix is NBTXR3 which is a radiosensitizer composed of hafnium oxide nanoparticles.

    Related Conference of Nanobiotix

    December 10-11, 2020

    21st World Summit on Nanotechnology and Expo

    Osaka, Japan
    February 10-11, 2021

    32nd European Congress on Nanotechnology and Materials Engineering

    Amsterdam, Netherlands
    February 26-26, 2021

    24th World Nanotechnology Congress

    Abu Dhabi, UAE
    April 28-29, 2021

    33rd Nano Congress for Future Advancements

    London, UK
    May 21-22, 2021

    18th Nanotechnology and Nano Medicine

    Osaka, Japan
    June 09-10, 2021

    6th Annual Conference and Expo on Biomaterials

    Berlin, Germany
    August 03-04, 2021

    4th World Congress on Nanoscience and Nano Technology

    Hanoi, Vietnam
    August 10-11, 2021

    5th Annual Congress on Nanomedicine and Drug Delivery

    Bangkok, Thailand
    November 15-16, 2021

    34th International Conference on Nanotechnology & Expo

    Madrid, Spain

    Nanobiotix Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in